JP2015513557A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015513557A5 JP2015513557A5 JP2014561064A JP2014561064A JP2015513557A5 JP 2015513557 A5 JP2015513557 A5 JP 2015513557A5 JP 2014561064 A JP2014561064 A JP 2014561064A JP 2014561064 A JP2014561064 A JP 2014561064A JP 2015513557 A5 JP2015513557 A5 JP 2015513557A5
- Authority
- JP
- Japan
- Prior art keywords
- agent according
- therapeutic agent
- pain
- peripheral neuropathy
- neuropathic pain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261608849P | 2012-03-09 | 2012-03-09 | |
| US61/608,849 | 2012-03-09 | ||
| PCT/US2013/029258 WO2013134336A2 (en) | 2012-03-09 | 2013-03-06 | Inhibition of adaptor associated kinase 1 for the treatment of pain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015513557A JP2015513557A (ja) | 2015-05-14 |
| JP2015513557A5 true JP2015513557A5 (enExample) | 2016-04-21 |
Family
ID=47884616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014561064A Pending JP2015513557A (ja) | 2012-03-09 | 2013-03-06 | 疼痛の治療に対するアダプター関連キナーゼ１の阻害 |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US20140080834A1 (enExample) |
| EP (2) | EP2822555B1 (enExample) |
| JP (1) | JP2015513557A (enExample) |
| CN (1) | CN104220071A (enExample) |
| AU (1) | AU2013230066A1 (enExample) |
| CA (1) | CA2866145A1 (enExample) |
| DK (1) | DK2822555T3 (enExample) |
| ES (1) | ES2657061T3 (enExample) |
| HK (1) | HK1199814A1 (enExample) |
| HU (1) | HUE036040T2 (enExample) |
| NO (1) | NO2935475T3 (enExample) |
| PL (1) | PL2822555T3 (enExample) |
| PT (1) | PT2822555T (enExample) |
| WO (1) | WO2013134336A2 (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2834243T3 (en) | 2012-03-09 | 2018-07-23 | Lexicon Pharmaceuticals Inc | Pyrazole [1,5-a] pyrimidine-based compounds, compositions comprising them and methods for their use |
| RU2014140739A (ru) * | 2012-03-09 | 2016-04-27 | Лексикон Фармасьютикалз, Инк. | Соединения на основе имидазо[1, 2-b]пиридазина, композиции таких соединений и способы их применения |
| US8901305B2 (en) | 2012-07-31 | 2014-12-02 | Bristol-Myers Squibb Company | Aryl lactam kinase inhibitors |
| EP2958924B1 (en) | 2013-02-22 | 2016-12-28 | Bristol-Myers Squibb Company | 5h-chromeno[3,4-c]pyridines as inhibitors of adaptor associated kinase 1 (aak1) |
| WO2014175370A1 (ja) * | 2013-04-25 | 2014-10-30 | 塩野義製薬株式会社 | ピロリジン誘導体およびそれらを含有する医薬組成物 |
| JP6434968B2 (ja) * | 2013-07-02 | 2018-12-05 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | Ｒｏｃｋ阻害剤としての三環式ピリド−カルボキサミド誘導体 |
| WO2015006100A1 (en) | 2013-07-08 | 2015-01-15 | Bristol-Myers Squibb Company | Aryl amide kinase inhibitors |
| AR097543A1 (es) * | 2013-09-06 | 2016-03-23 | Lexicon Pharmaceuticals Inc | COMPUESTOS BASADOS EN IMIDAZO[1,2-b]PIRIDAZINA, COMPOSICIONES QUE LOS COMPRENDEN Y SUS MÉTODOS DE USO |
| TW201542550A (zh) | 2013-09-06 | 2015-11-16 | Lexicon Pharmaceuticals Inc | 吡唑并［１，５－ａ］嘧啶基化合物、包含彼之組合物以及使用彼之方法 |
| MX2016002924A (es) * | 2013-09-11 | 2016-06-06 | Squibb Bristol Myers Co | Inhibidores de cinasa a base de eter arilico. |
| CN105979950A (zh) * | 2013-10-11 | 2016-09-28 | 百时美施贵宝公司 | 吡咯并三嗪激酶抑制剂 |
| ES2701903T3 (es) * | 2014-01-31 | 2019-02-26 | Bristol Myers Squibb Co | Inhibidores de cinasa a base de quinolina |
| TW201620911A (zh) * | 2014-03-17 | 2016-06-16 | 雷西肯製藥股份有限公司 | 銜接子關聯激酶１之抑制劑、包含其之組成物、及其使用方法 |
| CA2944466C (en) * | 2014-04-02 | 2020-06-09 | Bristol-Myers Squibb Company | Biaryl kinase inhibitors |
| US10035777B2 (en) | 2014-08-05 | 2018-07-31 | Bristol-Myers Squibb Company | Heterocyclic kinase inhibitors |
| EP3215511B1 (en) | 2014-11-06 | 2024-04-17 | Bial-R&D Investments, S.A. | Substituted pyrazolo(1,5-a)pyrimidines and their use in the treatment of medical disorders |
| EP3292124B1 (en) | 2015-04-10 | 2019-05-22 | Bristol-Myers Squibb Company | 6h-isochromeno[3,4-c]pyridines and benzo[c][1,7]naphthyridin-6-(5h)-ones as adaptor associated kinase 1 (aak1) inhibitors |
| ES2767776T3 (es) | 2015-10-01 | 2020-06-18 | Bristol Myers Squibb Co | Inhibidores de biaril cinasa |
| CN112142655A (zh) | 2015-10-01 | 2020-12-29 | 百时美施贵宝公司 | 联芳基激酶抑制剂 |
| WO2017176961A1 (en) | 2016-04-06 | 2017-10-12 | Lysosomal Therapeutics Inc. | Imidazo [1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders |
| KR20180133461A (ko) | 2016-04-06 | 2018-12-14 | 리소소말 테라퓨틱스 인크. | 피라졸로[1,5-a]피리미디닐 카르복스아미드 화합물 및 의학적 장애의 치료에서의 그의 용도 |
| WO2017192930A1 (en) * | 2016-05-05 | 2017-11-09 | Lysosomal Therapeutics Inc. | SUBSTITUTED IMIDAZO[1,2-b]PYRIDAZINES, SUBSTITUTED IMIDAZO[1,5-b]PYRIDAZINES, RELATED COMPOUNDS, AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS |
| US11352328B2 (en) | 2016-07-12 | 2022-06-07 | Arisan Therapeutics Inc. | Heterocyclic compounds for the treatment of arenavirus |
| US12419865B2 (en) | 2018-12-06 | 2025-09-23 | Arisan Therapeutics Inc. | Compounds for the treatment of arenavirus infection |
| KR102590438B1 (ko) * | 2020-10-16 | 2023-10-18 | 김홍렬 | Pmca 억제제를 포함하는 코로나바이러스 감염 또는 감염 질환의 예방 또는 소독용 조성물 |
| KR102590444B1 (ko) * | 2020-10-16 | 2023-10-18 | 김홍렬 | Pmca 억제제를 포함하는 코로나바이러스 감염 또는 감염 질환의 치료용 조성물 |
| WO2023196584A2 (en) * | 2022-04-08 | 2023-10-12 | New York University | Endocytosis inhibitors and their use for pain treatment |
| WO2025225608A1 (en) * | 2024-04-23 | 2025-10-30 | Otsuka Pharmaceutical Co., Ltd. | Tetrahydropyrazolopyridine derivative |
| WO2025230262A1 (ko) * | 2024-04-29 | 2025-11-06 | 심플렉스 주식회사 | 신규한 헤테로아릴 유도체 및 이의 aak1 억제 용도 |
| WO2026011102A2 (en) * | 2024-07-03 | 2026-01-08 | Board Of Regents, The University Of Texas System | Compositions and methods for treating cancer |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5464764A (en) | 1989-08-22 | 1995-11-07 | University Of Utah Research Foundation | Positive-negative selection methods and vectors |
| WO1993004169A1 (en) | 1991-08-20 | 1993-03-04 | Genpharm International, Inc. | Gene targeting in animal cells using isogenic dna constructs |
| US20070049591A1 (en) * | 2005-08-25 | 2007-03-01 | Kalypsys, Inc. | Inhibitors of MAPK/Erk Kinase |
| BRPI0718266A2 (pt) * | 2006-10-30 | 2014-01-07 | Novartis Ag | Compostos heterocíclicos como agentes anti-inflamatórios. |
| CA2722418C (en) * | 2008-05-13 | 2013-09-17 | Irm Llc | Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors |
| US8461336B2 (en) * | 2008-09-04 | 2013-06-11 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
-
2013
- 2013-03-06 HK HK15100206.3A patent/HK1199814A1/xx unknown
- 2013-03-06 PL PL13709722T patent/PL2822555T3/pl unknown
- 2013-03-06 CA CA2866145A patent/CA2866145A1/en not_active Abandoned
- 2013-03-06 EP EP13709722.6A patent/EP2822555B1/en active Active
- 2013-03-06 EP EP17175353.6A patent/EP3235499A3/en not_active Withdrawn
- 2013-03-06 WO PCT/US2013/029258 patent/WO2013134336A2/en not_active Ceased
- 2013-03-06 CN CN201380012478.XA patent/CN104220071A/zh active Pending
- 2013-03-06 PT PT137097226T patent/PT2822555T/pt unknown
- 2013-03-06 US US13/786,575 patent/US20140080834A1/en not_active Abandoned
- 2013-03-06 HU HUE13709722A patent/HUE036040T2/hu unknown
- 2013-03-06 AU AU2013230066A patent/AU2013230066A1/en not_active Abandoned
- 2013-03-06 ES ES13709722.6T patent/ES2657061T3/es active Active
- 2013-03-06 JP JP2014561064A patent/JP2015513557A/ja active Pending
- 2013-03-06 DK DK13709722.6T patent/DK2822555T3/en active
- 2013-12-11 NO NO13811839A patent/NO2935475T3/no unknown
-
2014
- 2014-08-07 US US14/453,666 patent/US20150164899A1/en not_active Abandoned
-
2016
- 2016-02-26 US US15/054,741 patent/US20160206619A1/en not_active Abandoned
-
2018
- 2018-04-30 US US15/966,274 patent/US20190134037A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015503422A5 (enExample) | ||
| JP2017506627A5 (enExample) | ||
| PT2976360T (pt) | Terapia envolvendo anticorpos contra claudina 18.2 para o tratamento de cancro | |
| JP2016028092A5 (enExample) | ||
| JP2015528502A5 (enExample) | ||
| CN109843873A (zh) | 炔代杂环化合物、其制备方法及其在医药学上的应用 | |
| JP2016065085A5 (enExample) | ||
| JP2014530840A5 (enExample) | ||
| EP2953624A4 (en) | METHOD FOR THE TREATMENT OF MICROBIAL INFECTIONS, INCLUDING MASTITIS | |
| EP3307738A4 (en) | ARYL-DIHYDRO-2H-BENZO [B] [1,4] OXAZINE-SULPHONAMIDE AND RELATED COMPOUNDS FOR USE AS AGENTS OF RORY AND FOR THE TREATMENT OF DISEASES | |
| CA2929436C (en) | Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases | |
| WO2015066302A3 (en) | Compositions, methods of use, and methods of treatment | |
| JP2013231052A5 (enExample) | ||
| NZ730816A (en) | Quinoline carboxamides for use in the treatment of multiple myeloma | |
| EA201692518A2 (ru) | Способы улучшения производительности миокарда у пациентов после операции фонтена с применением композиций уденафила | |
| CN109563051A (zh) | 作为pde4抑制剂的并环类化合物 | |
| JP2017014205A5 (enExample) | ||
| BR112014017493A2 (pt) | usos terapêuticos | |
| JP2015005289A5 (enExample) | ||
| WO2016073652A8 (en) | Iminosugars useful for the treatment of viral diseases | |
| ES2525079A1 (es) | Actividad antiparasitaria de escuaramidas | |
| IL260009B (en) | Novel bicyclic-compounds for use as a medicament, in particular for treatment of parkinson's disease | |
| LT3148588T (lt) | N,n-bis-2-merkaptoetilizoftalamidas, skirtas parkinsono ligos gydymui | |
| ICHIE | The Beginning of Music & Acoustical Medicine | |
| CN302314208S (zh) | 眼镜（tw13） |